GH Research
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GH Research and other ETFs, options, and stocks.About GHRS
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders.
CEOVelichka Valcheva
CEOVelichka Valcheva
Employees50
Employees50
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2021
Founded2021
Employees50
Employees50
GHRS Key Statistics
Market cap981.26M
Market cap981.26M
Price-Earnings ratio-20.80
Price-Earnings ratio-20.80
Dividend yield—
Dividend yield—
Average volume1.09M
Average volume1.09M
High today—
High today—
Low today—
Low today—
Open price$15.10
Open price$15.10
Volume0.00
Volume0.00
52 Week high$20.50
52 Week high$20.50
52 Week low$7.98
52 Week low$7.98
Stock Snapshot
With a market cap of 981.26M, GH Research(GHRS) trades at $14.90. The stock has a price-to-earnings ratio of -20.80.
GH Research(GHRS) stock opened on 2026-01-13 at $15.10. The price climbed to — and dipped to —.
The GH Research(GHRS)'s current trading volume is 0, compared to an average daily volume of 1.09M.
During the past year, GH Research(GHRS) stock moved between $7.98 at its lowest and $20.50 at its peak.
During the past year, GH Research(GHRS) stock moved between $7.98 at its lowest and $20.50 at its peak.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own GHRS. This list is generated using Robinhood data, and it’s not a recommendation.